Phase 2B Study on Safety and Therapeutic Efficacy of DAS181 in Adult Subjects With Naturally Acquired Influenza

NCT01740063 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

423

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: DAS181-F02 formulation
DRUG: DAS181-F04 formulation
DRUG: Placebo

Sponsor

Ansun Biopharma, Inc.